Global Veterinary Pharmaceuticals Market Size Study and Forecast by Type, by Application, by Animal Type, by End User, by Distribution Channel, and Regional Forecasts 2025-2035

Description

Market Definition, Recent Developments & Industry Trends

The veterinary pharmaceuticals market comprises medicinal products and diagnostic solutions developed for the prevention, management, and treatment of diseases in animals. This includes therapeutics such as anti-infectives, vaccines, parasiticides, anti-inflammatory agents, and oncology drugs, as well as diagnostic tools supporting disease identification and monitoring. The market ecosystem includes pharmaceutical manufacturers, biotechnology firms, veterinary service providers, research institutions, livestock producers, regulatory bodies, and distribution networks serving both companion and production animal segments.

In recent years, the market has evolved in response to rising pet ownership, increased livestock production, and heightened awareness of zoonotic disease risks. Advances in biologics, precision diagnostics, and vaccine development have strengthened treatment efficacy and disease prevention capabilities. Regulatory oversight regarding antimicrobial usage and animal welfare standards has further shaped product innovation strategies. Additionally, digital health tools and point-of-care diagnostics are enhancing clinical efficiency in veterinary settings. Over the forecast period to 2035, the market is expected to demonstrate sustained expansion, supported by growing demand for animal health management, biosecurity measures, and integrated veterinary care models.

Key Findings of the Report

Market Size (2024): USD 49.6 billion
Estimated Market Size (2035): USD 105.48 billion
CAGR (2025-2035): 7.10%
Leading Regional Market: North America
Leading Segment: Therapeutics under Type

Market Determinants

Rising Pet Ownership and Humanization Trends

The increasing adoption of companion animals and the growing trend of pet humanization are significantly expanding expenditure on advanced veterinary treatments. Owners are increasingly willing to invest in specialized therapies, chronic disease management, and preventive care, directly stimulating pharmaceutical demand.

Expansion of Livestock Production and Food Security Priorities

Global demand for protein-rich diets has intensified livestock production. Effective disease prevention and control measures are essential to maintain herd productivity and food safety standards. Veterinary pharmaceuticals play a critical role in minimizing economic losses caused by infectious and parasitic diseases.

Technological Advancements in Biologics and Vaccines

Innovations in biotechnology, including recombinant vaccines and targeted biologics, are enhancing treatment precision and safety. Improved diagnostics also support early detection and optimized therapeutic intervention, strengthening overall market value.

Regulatory Controls on Antimicrobial Usage

Increasing global scrutiny over antimicrobial resistance is reshaping pharmaceutical development and prescribing patterns. While stricter regulations may constrain certain drug categories, they also encourage innovation in alternative therapeutics and preventive solutions.

Cost Sensitivity and Access Limitations in Emerging Markets

High treatment costs and limited veterinary infrastructure in developing regions may restrict adoption rates. Pricing pressures and uneven reimbursement structures present challenges for market expansion, particularly in production animal segments.

Opportunity Mapping Based on Market Trends

Growth in Companion Animal Specialty Care

Rising demand for oncology treatments, dermatology solutions, and chronic disease management in companion animals presents a high-value opportunity. Pharmaceutical companies focusing on premium therapeutics can capitalize on expanding pet healthcare expenditure.

Expansion of Preventive Vaccination Programs

Increased awareness of zoonotic diseases and transboundary infections such as foot and mouth disease and bluetongue is driving investment in vaccination campaigns. This trend creates scalable opportunities in both developed and emerging markets.

Point-of-Care and In-House Diagnostic Testing

The adoption of rapid diagnostic technologies within veterinary clinics enhances treatment accuracy and efficiency. Companies offering integrated therapeutic-diagnostic solutions can strengthen competitive positioning.

Emerging Market Livestock Modernization

Improved farming practices and biosecurity investments in Asia Pacific, Latin America, and parts of Africa offer growth potential for veterinary pharmaceutical providers targeting production animal segments.

Key Market Segments

By Type:

Therapeutics
Diagnostics

By Application:

Bacterial Diseases
Canine Atopic Dermatitis
Helminthes Infection
Animal Cancer
Foot and Mouth Disease
Autoimmune Diseases
Bluetongue
Others

By Animal Type:

Companion Animals
Production Animal

By End User:

Veterinary Hospitals
Veterinary Clinics
Animal and Veterinary Farms
Reference Laboratories
Academic and Research Institute
Point-Of-Care Testing/In-House Testing
Others

By Distribution Channel:

Retail Sales
Direct Tender
Others

Value-Creating Segments and Growth Pockets

Therapeutics currently account for the largest revenue share, driven by high demand for anti-infectives, vaccines, and parasiticides across both companion and production animals. Diagnostics, while smaller in share, are expected to grow steadily as early detection and precision treatment become integral to veterinary care.

Among applications, Bacterial Diseases and Helminthes Infection represent established revenue contributors, particularly in livestock. However, Animal Cancer and Canine Atopic Dermatitis are anticipated to grow faster due to increasing companion animal healthcare expenditure. By animal type, Companion Animals are expected to demonstrate stronger value growth compared to Production Animals, reflecting premiumization trends in pet care. In distribution channels, Retail Sales dominate, while Direct Tender remains significant in government-led livestock vaccination programs.

Regional Market Assessment

North America

North America leads the global market, supported by advanced veterinary infrastructure, high pet ownership rates, and robust R&D investments. Strong regulatory frameworks and premium product adoption further reinforce regional dominance.

Europe

Europe demonstrates stable growth driven by stringent animal welfare regulations and proactive disease surveillance systems. Increasing demand for sustainable livestock practices and reduced antimicrobial usage shapes innovation trends.

Asia Pacific

Asia Pacific is projected to witness accelerated growth, fueled by expanding livestock industries, rising disposable incomes, and growing pet adoption. Investments in veterinary infrastructure modernization are supporting market expansion.

LAMEA

The LAMEA region presents significant long-term potential, particularly in livestock disease management. Government-led vaccination initiatives and agricultural modernization programs are key growth enablers.

Recent Developments

February 2024: A global animal health company launched a next-generation vaccine targeting transboundary livestock diseases, strengthening preventive healthcare capabilities in production animals.
August 2024: A veterinary pharmaceutical firm introduced an advanced biologic therapy for canine dermatological conditions, reflecting rising demand for companion animal specialty treatments.
January 2025: A multinational company expanded its diagnostic product portfolio with rapid point-of-care testing kits, enhancing clinical efficiency in veterinary clinics.

Critical Business Questions Addressed

What is the long-term revenue outlook for the veterinary pharmaceuticals market?

The report outlines growth from USD 49.6 billion in 2024 to USD 105.48 billion by 2035, reflecting sustained expansion at a CAGR of 7.10%.

Which application areas offer the strongest growth potential?

Companion animal oncology, dermatology, and preventive vaccination programs present high-value growth opportunities.

How are regulatory trends influencing product development strategies?

Stricter antimicrobial regulations are accelerating innovation in biologics, vaccines, and alternative therapies.

Which end-user segments drive demand concentration?

Veterinary hospitals and clinics dominate, while point-of-care testing facilities are emerging as growth accelerators.

What strategic priorities should pharmaceutical companies adopt?

Investment in R&D, expansion in emerging markets, and integration of diagnostics with therapeutics will define competitive advantage.

Beyond the Forecast

The veterinary pharmaceuticals market is transitioning toward integrated and preventive care models, emphasizing early diagnosis, targeted treatment, and biosecurity. Long-term value creation will depend on balancing innovation with regulatory compliance and cost accessibility.

As companion animal healthcare premiumizes and livestock biosecurity intensifies, companies that align product portfolios with evolving disease patterns and sustainability goals will secure durable competitive positioning in the global animal health ecosystem.

Chapter 1. Global Veterinary Pharmaceuticals Market Report Scope & Methodology

1.1. Market Definition
1.2. Market Segmentation
1.3. Research Assumption
- 1.3.1. Inclusion & Exclusion
- 1.3.2. Limitations
1.4. Research Objective
1.5. Research Methodology
- 1.5.1. Forecast Model
- 1.5.2. Desk Research
- 1.5.3. Top Down and Bottom-Up Approach
1.6. Research Attributes
1.7. Years Considered for the Study

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Strategic Insights
2.3. Top Findings
2.4. CEO/CXO Standpoint
2.5. ESG Analysis

Chapter 3. Global Veterinary Pharmaceuticals Market Forces Analysis

3.1. Market Forces Shaping The Global Veterinary Pharmaceuticals Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising Pet Ownership and Humanization Trends
- 3.2.2. Expansion of Livestock Production and Food Security Priorities
- 3.2.3. Technological Advancements in Biologics and Vaccines
- 3.2.4. Regulatory Controls on Antimicrobial Usage
3.3. Restraints
- 3.3.1. Cost Sensitivity and Access Limitations in Emerging Markets
- 3.3.2. Pricing pressures and uneven reimbursement structures
3.4. Opportunities
- 3.4.1. Growth in Companion Animal Specialty Care
- 3.4.2. Expansion of Preventive Vaccination Programs

Chapter 4. Global Veterinary Pharmaceuticals Industry Analysis

4.1. Porter's 5 Forces Model
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.4. Macroeconomic Industry Trends
- 4.4.1. Parent Market Trends
- 4.4.2. GDP Trends & Forecasts
4.5. Value Chain Analysis
4.6. Top Investment Trends & Forecasts
4.7. Top Winning Strategies (2025)
4.8. Market Share Analysis (2024-2025)
4.9. Pricing Analysis
4.10. Investment & Funding Scenario
4.11. Impact of Geopolitical & Trade Policy Volatility on the Market

Chapter 5. AI Adoption Trends and Market Influence

5.1. AI Readiness Index
5.2. Key Emerging Technologies
5.3. Patent Analysis
5.4. Top Case Studies

Chapter 6. Global Veterinary Pharmaceuticals Market Size & Forecasts by Type 2025-2035

6.1. Market Overview
6.2. Global Veterinary Pharmaceuticals Market Performance - Potential Analysis (2025)
6.3. Therapeutics
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Diagnostics
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Veterinary Pharmaceuticals Market Size & Forecasts by Application 2025-2035

7.1. Market Overview
7.2. Global Veterinary Pharmaceuticals Market Performance - Potential Analysis (2025)
7.3. Bacterial Diseases
- 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.3.2. Market size analysis, by region, 2025-2035
7.4. Canine Atopic Dermatitis
- 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.4.2. Market size analysis, by region, 2025-2035
7.5. Helminthes Infection
- 7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.5.2. Market size analysis, by region, 2025-2035
7.6. Animal Cancer
- 7.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.6.2. Market size analysis, by region, 2025-2035
7.7. Foot and Mouth Disease
- 7.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.7.2. Market size analysis, by region, 2025-2035
7.8. Autoimmune Diseases
- 7.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.8.2. Market size analysis, by region, 2025-2035
7.9. Bluetongue
- 7.9.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.9.2. Market size analysis, by region, 2025-2035
7.10. Others
- 7.10.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.10.2. Market size analysis, by region, 2025-2035

Chapter 8. Global Veterinary Pharmaceuticals Market Size & Forecasts by Animal Type 2025-2035

8.1. Market Overview
8.2. Global Veterinary Pharmaceuticals Market Performance - Potential Analysis (2025)
8.3. Companion Animals
- 8.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 8.3.2. Market size analysis, by region, 2025-2035
8.4. Production Animal
- 8.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 8.4.2. Market size analysis, by region, 2025-2035

Chapter 9. Global Veterinary Pharmaceuticals Market Size & Forecasts by End User 2025-2035

9.1. Market Overview
9.2. Global Veterinary Pharmaceuticals Market Performance - Potential Analysis (2025)
9.3. Veterinary Hospitals
- 9.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 9.3.2. Market size analysis, by region, 2025-2035
9.4. Veterinary Clinics
- 9.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 9.4.2. Market size analysis, by region, 2025-2035
9.5. Animal and Veterinary Farms
- 9.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 9.5.2. Market size analysis, by region, 2025-2035
9.6. Reference Laboratories
- 9.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 9.6.2. Market size analysis, by region, 2025-2035
9.7. Academic and Research Institute
- 9.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 9.7.2. Market size analysis, by region, 2025-2035
9.8. Point-Of-Care Testing/In-House Testing
- 9.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 9.8.2. Market size analysis, by region, 2025-2035
9.9. Others
- 9.9.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 9.9.2. Market size analysis, by region, 2025-2035

Chapter 10. Global Veterinary Pharmaceuticals Market Size & Forecasts by Distribution Channel 2025-2035

10.1. Market Overview
10.2. Global Veterinary Pharmaceuticals Market Performance - Potential Analysis (2025)
10.3. Retail Sales
- 10.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 10.3.2. Market size analysis, by region, 2025-2035
10.4. Direct Tender
- 10.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 10.4.2. Market size analysis, by region, 2025-2035
10.5. Others
- 10.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 10.5.2. Market size analysis, by region, 2025-2035

Chapter 11. Global Veterinary Pharmaceuticals Market Size & Forecasts by Region 2025-2035

11.1. Growth Veterinary Pharmaceuticals Market, Regional Market Snapshot
11.2. Top Leading & Emerging Countries
11.3. North America Veterinary Pharmaceuticals Market
- 11.3.1. U.S. Veterinary Pharmaceuticals Market
  - 11.3.1.1. Type breakdown size & forecasts, 2025-2035
  - 11.3.1.2. Application breakdown size & forecasts, 2025-2035
  - 11.3.1.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.3.1.4. End User breakdown size & forecasts, 2025-2035
  - 11.3.1.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.3.2. Canada Veterinary Pharmaceuticals Market
  - 11.3.2.1. Type breakdown size & forecasts, 2025-2035
  - 11.3.2.2. Application breakdown size & forecasts, 2025-2035
  - 11.3.2.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.3.2.4. End User breakdown size & forecasts, 2025-2035
  - 11.3.2.5. Distribution channel breakdown size & forecasts, 2025-2035
11.4. Europe Veterinary Pharmaceuticals Market
- 11.4.1. UK Veterinary Pharmaceuticals Market
  - 11.4.1.1. Type breakdown size & forecasts, 2025-2035
  - 11.4.1.2. Application breakdown size & forecasts, 2025-2035
  - 11.4.1.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.4.1.4. End User breakdown size & forecasts, 2025-2035
  - 11.4.1.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.4.2. Germany Veterinary Pharmaceuticals Market
  - 11.4.2.1. Type breakdown size & forecasts, 2025-2035
  - 11.4.2.2. Application breakdown size & forecasts, 2025-2035
  - 11.4.2.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.4.2.4. End User breakdown size & forecasts, 2025-2035
  - 11.4.2.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.4.3. France Veterinary Pharmaceuticals Market
  - 11.4.3.1. Type breakdown size & forecasts, 2025-2035
  - 11.4.3.2. Application breakdown size & forecasts, 2025-2035
  - 11.4.3.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.4.3.4. End User breakdown size & forecasts, 2025-2035
  - 11.4.3.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.4.4. Spain Veterinary Pharmaceuticals Market
  - 11.4.4.1. Type breakdown size & forecasts, 2025-2035
  - 11.4.4.2. Application breakdown size & forecasts, 2025-2035
  - 11.4.4.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.4.4.4. End User breakdown size & forecasts, 2025-2035
  - 11.4.4.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.4.5. Italy Veterinary Pharmaceuticals Market
  - 11.4.5.1. Type breakdown size & forecasts, 2025-2035
  - 11.4.5.2. Application breakdown size & forecasts, 2025-2035
  - 11.4.5.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.4.5.4. End User breakdown size & forecasts, 2025-2035
  - 11.4.5.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.4.6. Rest of Europe Veterinary Pharmaceuticals Market
  - 11.4.6.1. Type breakdown size & forecasts, 2025-2035
  - 11.4.6.2. Application breakdown size & forecasts, 2025-2035
  - 11.4.6.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.4.6.4. End User breakdown size & forecasts, 2025-2035
  - 11.4.6.5. Distribution channel breakdown size & forecasts, 2025-2035
11.5. Asia Pacific Veterinary Pharmaceuticals Market
- 11.5.1. China Veterinary Pharmaceuticals Market
  - 11.5.1.1. Type breakdown size & forecasts, 2025-2035
  - 11.5.1.2. Application breakdown size & forecasts, 2025-2035
  - 11.5.1.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.5.1.4. End User breakdown size & forecasts, 2025-2035
  - 11.5.1.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.5.2. India Veterinary Pharmaceuticals Market
  - 11.5.2.1. Type breakdown size & forecasts, 2025-2035
  - 11.5.2.2. Application breakdown size & forecasts, 2025-2035
  - 11.5.2.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.5.2.4. End User breakdown size & forecasts, 2025-2035
  - 11.5.2.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.5.3. Japan Veterinary Pharmaceuticals Market
  - 11.5.3.1. Type breakdown size & forecasts, 2025-2035
  - 11.5.3.2. Application breakdown size & forecasts, 2025-2035
  - 11.5.3.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.5.3.4. End User breakdown size & forecasts, 2025-2035
  - 11.5.3.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.5.4. Australia Veterinary Pharmaceuticals Market
  - 11.5.4.1. Type breakdown size & forecasts, 2025-2035
  - 11.5.4.2. Application breakdown size & forecasts, 2025-2035
  - 11.5.4.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.5.4.4. End User breakdown size & forecasts, 2025-2035
  - 11.5.4.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.5.5. South Korea Veterinary Pharmaceuticals Market
  - 11.5.5.1. Type breakdown size & forecasts, 2025-2035
  - 11.5.5.2. Application breakdown size & forecasts, 2025-2035
  - 11.5.5.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.5.5.4. End User breakdown size & forecasts, 2025-2035
  - 11.5.5.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.5.6. Rest of APAC Veterinary Pharmaceuticals Market
  - 11.5.6.1. Type breakdown size & forecasts, 2025-2035
  - 11.5.6.2. Application breakdown size & forecasts, 2025-2035
  - 11.5.6.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.5.6.4. End User breakdown size & forecasts, 2025-2035
  - 11.5.6.5. Distribution channel breakdown size & forecasts, 2025-2035
11.6. Latin America Veterinary Pharmaceuticals Market
- 11.6.1. Brazil Veterinary Pharmaceuticals Market
  - 11.6.1.1. Type breakdown size & forecasts, 2025-2035
  - 11.6.1.2. Application breakdown size & forecasts, 2025-2035
  - 11.6.1.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.6.1.4. End User breakdown size & forecasts, 2025-2035
  - 11.6.1.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.6.2. Mexico Veterinary Pharmaceuticals Market
  - 11.6.2.1. Type breakdown size & forecasts, 2025-2035
  - 11.6.2.2. Application breakdown size & forecasts, 2025-2035
  - 11.6.2.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.6.2.4. End User breakdown size & forecasts, 2025-2035
  - 11.6.2.5. Distribution channel breakdown size & forecasts, 2025-2035
11.7. Middle East and Africa Veterinary Pharmaceuticals Market
- 11.7.1. UAE Veterinary Pharmaceuticals Market
  - 11.7.1.1. Type breakdown size & forecasts, 2025-2035
  - 11.7.1.2. Application breakdown size & forecasts, 2025-2035
  - 11.7.1.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.7.1.4. End User breakdown size & forecasts, 2025-2035
  - 11.7.1.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.7.2. Saudi Arabia (KSA) Veterinary Pharmaceuticals Market
  - 11.7.2.1. Type breakdown size & forecasts, 2025-2035
  - 11.7.2.2. Application breakdown size & forecasts, 2025-2035
  - 11.7.2.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.7.2.4. End User breakdown size & forecasts, 2025-2035
  - 11.7.2.5. Distribution channel breakdown size & forecasts, 2025-2035
- 11.7.3. South Africa Veterinary Pharmaceuticals Market
  - 11.7.3.1. Type breakdown size & forecasts, 2025-2035
  - 11.7.3.2. Application breakdown size & forecasts, 2025-2035
  - 11.7.3.3. Animal Type breakdown size & forecasts, 2025-2035
  - 11.7.3.4. End User breakdown size & forecasts, 2025-2035
  - 11.7.3.5. Distribution channel breakdown size & forecasts, 2025-2035

Chapter 12. Competitive Intelligence

12.1. Top Market Strategies
12.2. Zoetis Services LLC
- 12.2.1. Company Overview
- 12.2.2. Key Executives
- 12.2.3. Company Snapshot
- 12.2.4. Financial Performance (Subject to Data Availability)
- 12.2.5. Product/Services Port
- 12.2.6. Recent Development
- 12.2.7. Market Strategies
- 12.2.8. SWOT Analysis
12.3. Merck & Co.
12.4. Inc.
12.5. Elanco or its affiliates.
12.6. Boehringer Ingelheim International GmbH and IDEXX LABORATORIES
12.7. AB Science
12.8. AdvaCare Pharma
12.9. ALMAX IMAGING srl
12.10. Anivive
12.11. BIOMERIEUX